Staar Surgical Co. (STAA) Shares See 7.66% Rise Over Last Week

At the time of writing, Staar Surgical Co. [STAA] stock is trading at $35.86, up 2.14%. An important factor to consider is whether the stock is rising or falling in short-term value. The STAA shares have gain 7.66% over the last week, with a monthly amount glided 20.90%, and seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

On 6, March 2024, STAAR Surgical to Participate in Two Upcoming Investor Conferences. In a post published today on Yahoo Finance, STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that management will participate in meetings with investors at the following conferences:.

From an analyst’s perspective:

Staar Surgical Co. [NASDAQ: STAA] stock has seen the most recent analyst activity on December 05, 2023, when Needham downgraded its rating to a Hold. Previously, Morgan Stanley started tracking the stock with Equal-Weight rating on December 04, 2023, and set its price target to $35. On September 15, 2023, downgrade downgraded it’s rating to Hold. Canaccord Genuity downgraded its rating to a Hold and decreased its price target to $48 on August 03, 2023. William Blair downgraded its rating to a Mkt Perform. Piper Sandler started tracking with a Neutral rating for this stock on April 17, 2023, and assigned it a price target of $65. In a note dated February 06, 2023, BTIG Research downgraded an Neutral rating on this stock.

For the past year, the stock price of Staar Surgical Co. fluctuated between $26.66 and $73.13. Currently, Wall Street analysts expect the stock to reach $68.5 within the next 12 months. Staar Surgical Co. [NASDAQ: STAA] shares were valued at $35.86 at the most recent close of the market. An investor can expect a potential return of 91.02% based on the average STAA price forecast.

Analyzing the STAA fundamentals

According to Staar Surgical Co. [NASDAQ:STAA], the company’s sales were 322.42M for trailing twelve months, which represents an 19.09% jump. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.1%, and Net Profit Margin reading is 0.07%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.06 and Total Capital is 0.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.09.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 35.07 points at the first support level, and at 34.28 for the second support level. However, for the 1st resistance point, the stock is sitting at 36.92, and for the 2nd resistance point, it is at 37.99.

Staar Surgical Co. [STAA] reported earnings per share of $0.13 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.17/share, meaning a difference of -$0.04 and a surprise factor of -23.50%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.3 per share as compared to estimates of $0.18 per share, a difference of $0.12 representing a surprise of 66.70%.

Ratios To Look Out For

It is important to note that Staar Surgical Co. [NASDAQ:STAA] has a current ratio of 5.62. On the other hand, the Quick Ratio is 5.08, and the Cash Ratio is 2.81. Considering the valuation of this stock, the price to sales ratio is 5.44, the price to book ratio is 4.54 and price to earnings (TTM) ratio is 82.95.

Transactions by insiders

Recent insider trading involved BROADWOOD PARTNERS, L.P., 10% Owner, that happened on Jan 08 ’24 when 4042.0 shares were purchased. 10% Owner, BROADWOOD PARTNERS, L.P. completed a deal on Jan 05 ’24 to buy 0.16 million shares. Meanwhile, 10% Owner BROADWOOD PARTNERS, L.P. bought 63246.0 shares on Jan 04 ’24.

Related Posts